{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:40:41Z","timestamp":1768477241295,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,16]]},"DOI":"10.7759\/cureus.71605","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:48:20Z","timestamp":1729079300000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparative Study of Metabolic Tumor Volume in Multiple Myeloma and Related Plasma Cell Dyscrasias: 11C-Acetate PET vs. 18F-FDG PET"],"prefix":"10.7759","author":[{"given":"Momo","family":"Wakui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikara","family":"Kase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-014-0308-3","article-title":"\u00b9\u2078F-FDG PET\/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders","volume":"15","author":"Dammacco F","year":"2015","unstructured":"Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V. \u00b9\u2078F-FDG PET\/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Clin Exp Med. 2015, 15:1-18. 10.1007\/s10238-014-0308-3","journal-title":"Clin Exp Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"Rajkumar SV","year":"2016","unstructured":"Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016, 91:101-19. 10.1016\/j.mayocp.2015.11.007","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren O","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, et al.. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009, 113:5412-7. 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri A","year":"2017","unstructured":"Dispenzieri A. POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017, 92:814-29. 10.1002\/ajh.24802","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0829-0","article-title":"Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma","volume":"88","author":"L\u00fctje S","year":"2009","unstructured":"L\u00fctje S, de Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET\/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009, 88:1161-8. 10.1007\/s00277-009-0829-0","journal-title":"Ann Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-002-0580-2","article-title":"Diagnostic utility of FDG PET in multiple myeloma","volume":"31","author":"Jadvar H","year":"2002","unstructured":"Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002, 31:690-4. 10.1007\/s00256-002-0580-2","journal-title":"Skeletal Radiol"},{"key":"ref8","article-title":"Whole-body 18F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie BG","year":"2002","unstructured":"Durie BG, Waxman AD, D'Agnolo A, et al.. Whole-body 18F-FDG PET identifies high-risk myeloma. J Nucl Med. 2002, 43:1457-63.","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister H","year":"2002","unstructured":"Schirrmeister H, Bommer M, Buck AK, et al.. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2002, 29:361-6. 10.1007\/s00259-001-0711-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.184.4.01841199","article-title":"Value of FDG PET in the assessment of patients with multiple myeloma","volume":"184","author":"Bredella MA","year":"2005","unstructured":"Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005, 184:1199-204. 10.2214\/ajr.184.4.01841199","journal-title":"AJR Am J Roentgenol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/583439","article-title":"Multiple myeloma: a review of imaging features and radiological techniques","volume":"2011","author":"Healy CF","year":"2011","unstructured":"Healy CF, Murray JG, Eustace SJ, Madewell J, O'Gorman PJ, O'Sullivan P. Multiple myeloma: a review of imaging features and radiological techniques. Bone Marrow Res. 2011, 2011:583439. 10.1155\/2011\/583439","journal-title":"Bone Marrow Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.573036","article-title":"Current and future imaging modalities for multiple myeloma and its precursor states","volume":"52","author":"Tan E","year":"2011","unstructured":"Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O. Current and future imaging modalities for multiple myeloma and its precursor states. Leuk Lymphoma. 2011, 52:1630-40. 10.3109\/10428194.2011.573036","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/175803","article-title":"The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to treatment in patients with multiple myeloma","volume":"2012","author":"Caldarella C","year":"2012","unstructured":"Caldarella C, Treglia G, Isgr\u00f2 MA, Treglia I, Giordano A. The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to treatment in patients with multiple myeloma. Int J Mol Imaging. 2012, 2012:175803. 10.1155\/2012\/175803","journal-title":"Int J Mol Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni E","year":"2007","unstructured":"Zamagni E, Nanni C, Patriarca F, et al.. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica. 2007, 92:50-5. 10.3324\/haematol.10554","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-body MRI versus PET in assessment of multiple myeloma disease activity","volume":"192","author":"Shortt CP","year":"2009","unstructured":"Shortt CP, Gleeson TG, Breen KA, McHugh J, O'Connell MJ, O'Gorman PJ, Eustace SJ. Whole-body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol. 2009, 192:980-6. 10.2214\/AJR.08.1633","journal-title":"AJR Am J Roentgenol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","author":"Nanni C","year":"2007","unstructured":"Nanni C, Zamagni E, Cavo M, et al.. 11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma. World J Surg Oncol. 2007, 5:68. 10.1186\/1477-7819-5-68","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2333-3","article-title":"Clinical value of \u00b9\u00b9C-methionine PET\/CT in patients with plasma cell malignancy: comparison with \u00b9\u2078F-FDG PET\/CT","volume":"40","author":"Nakamoto Y","year":"2013","unstructured":"Nakamoto Y, Kurihara K, Nishizawa M, et al.. Clinical value of \u00b9\u00b9C-methionine PET\/CT in patients with plasma cell malignancy: comparison with \u00b9\u2078F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2013, 40:708-15. 10.1007\/s00259-012-2333-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3053","article-title":"11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma","volume":"6","author":"L\u00fcckerath K","year":"2015","unstructured":"L\u00fcckerath K, Lapa C, Albert C, et al.. 11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma. Oncotarget. 2015, 6:8418-29. 10.18632\/oncotarget.3053","journal-title":"Oncotarget"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.169599","article-title":"Evaluation of prostate cancer with 11C-acetate PET\/CT","volume":"57","author":"Spick C","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J. Evaluation of prostate cancer with 11C-acetate PET\/CT. J Nucl Med. 2016, 57:30-7. 10.2967\/jnumed.115.169599","journal-title":"J Nucl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203889","article-title":"Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway","volume":"19","author":"Swinnen JV","year":"2000","unstructured":"Swinnen JV, Heemers H, Deboel L, et al.. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000, 19:5173-81. 10.1038\/sj.onc.1203889","journal-title":"Oncogene"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.062703","article-title":"The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma","volume":"50","author":"Yun M","year":"2009","unstructured":"Yun M, Bang SH, Kim JW, Park JY, Kim KS, Lee JD. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. J Nucl Med. 2009, 50:1222-8. 10.2967\/jnumed.109.062703","journal-title":"J Nucl Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002464","article-title":"Tumor identification of less aggressive or indolent lymphoma with whole-body 11C-acetate PET\/CT","volume":"44","author":"Tsuchiya J","year":"2019","unstructured":"Tsuchiya J, Yamamoto M, Bae H, Oshima T, Yoneyama T, Miura O, Tateishi U. Tumor identification of less aggressive or indolent lymphoma with whole-body 11C-acetate PET\/CT. Clin Nucl Med. 2019, 44:276-81. 10.1097\/RLU.0000000000002464","journal-title":"Clin Nucl Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2134","article-title":"Evaluating acetate metabolism for imaging and targeting in multiple myeloma","volume":"23","author":"Fontana F","year":"2017","unstructured":"Fontana F, Ge X, Su X, et al.. Evaluating acetate metabolism for imaging and targeting in multiple myeloma. Clin Cancer Res. 2017, 23:416-29. 10.1158\/1078-0432.CCR-15-2134","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131169","article-title":"11C-acetate PET\/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET\/CT","volume":"55","author":"Ho CL","year":"2014","unstructured":"Ho CL, Chen S, Leung YL, et al.. 11C-acetate PET\/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET\/CT. J Nucl Med. 2014, 55:749-52. 10.2967\/jnumed.113.131169","journal-title":"J Nucl Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2520-x","article-title":"11C-acetate as a new biomarker for PET\/CT in patients with multiple myeloma: initial staging and postinduction response assessment","volume":"41","author":"Lin C","year":"2014","unstructured":"Lin C, Ho CL, Ng SH, et al.. 11C-acetate as a new biomarker for PET\/CT in patients with multiple myeloma: initial staging and postinduction response assessment. Eur J Nucl Med Mol Imaging. 2014, 41:41-9. 10.1007\/s00259-013-2520-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.106500","article-title":"Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma","volume":"53","author":"Fonti R","year":"2012","unstructured":"Fonti R, Larobina M, Del Vecchio S, et al.. Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma. J Nucl Med. 2012, 53:1829-35. 10.2967\/jnumed.112.106500","journal-title":"J Nucl Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0235","article-title":"Assessment of total lesion glycolysis by 18F FDG PET\/CT significantly improves prognostic value of GEP and ISS in myeloma","volume":"23","author":"McDonald JE","year":"2017","unstructured":"McDonald JE, Kessler MM, Gardner MW, et al.. Assessment of total lesion glycolysis by 18F FDG PET\/CT significantly improves prognostic value of GEP and ISS in myeloma. Clin Cancer Res. 2017, 23:1981-7. 10.1158\/1078-0432.CCR-16-0235","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from International Myeloma Working Group","volume":"33","author":"Palumbo A","year":"2015","unstructured":"Palumbo A, Avet-Loiseau H, Oliva S, et al.. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015, 33:2863-9. 10.1200\/JCO.2015.61.2267","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0020-708x(82)90003-5","article-title":"Preparation of [1\u221211C]acetate\u2014an agent for the study of myocardial metabolism by positron emission tomography","volume":"33","author":"Pike VW","year":"1982","unstructured":"Pike VW, Eakins MN, Allan RM, et al.. Preparation of [1\u221211C]acetate\u2014an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot. 1982, 33:505-12. 10.1016\/0020-708x(82)90003-5","journal-title":"Int J Appl Radiat Isot"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0969-8043(95)00008-2","article-title":"A practical method for the preparation of [11C]acetate","volume":"317","author":"Kruijer PS","year":"1995","unstructured":"Kruijer PS, Linden TT, Mooij R, et al.. A practical method for the preparation of [11C]acetate. Appl Radiat Isot. 1995, 317:321. 10.1016\/0969-8043(95)00008-2","journal-title":"Appl Radiat Isot"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-8. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361386","article-title":"Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation","volume":"118","author":"Zamagni E","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, et al.. Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood. 2011, 118:5989-95. 10.1182\/blood-2011-06-361386","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.160507","article-title":"Characterizing POEMS syndrome with 18F-FDG PET\/CT","volume":"56","author":"Pan Q","year":"2015","unstructured":"Pan Q, Li J, Li F, et al.. Characterizing POEMS syndrome with 18F-FDG PET\/CT. J Nucl Med. 2015, 56:1334-7. 10.2967\/jnumed.115.160507","journal-title":"J Nucl Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.53.2013","article-title":"Usefulness of 18F-FDG PET\/CT for detecting lesions in patients with POEMS syndrome","volume":"53","author":"Tanaka N","year":"2012","unstructured":"Tanaka N, Yoshinaga K, Asano C, et al.. Usefulness of 18F-FDG PET\/CT for detecting lesions in patients with POEMS syndrome. Rinsho Ketsueki. 2012, 53:2013-7. 10.11406\/rinketsu.53.2013","journal-title":"Rinsho Ketsueki"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.06.004","article-title":"18F-FDG PET\/CT in the evaluation of POEMS syndrome","volume":"76","author":"Albert\u00ed MA","year":"2010","unstructured":"Albert\u00ed MA, Martinez-Y\u00e9lamos S, Fernandez A, et al.. 18F-FDG PET\/CT in the evaluation of POEMS syndrome. Eur J Radiol. 2010, 76:180-2. 10.1016\/j.ejrad.2009.06.004","journal-title":"Eur J Radiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2017.09.005","article-title":"Metabolic tumor volume metrics in lymphoma","volume":"48","author":"Kostakoglu L","year":"2018","unstructured":"Kostakoglu L, Chauvie S. Metabolic tumor volume metrics in lymphoma. Semin Nucl Med. 2018, 48:50-66. 10.1053\/j.semnuclmed.2017.09.005","journal-title":"Semin Nucl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304206-comparative-study-of-metabolic-tumor-volume-in-multiple-myeloma-and-related-plasma-cell-dyscrasias-11c-acetate-pet-vs-18f-fdg-pet","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T11:48:24Z","timestamp":1729079304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304206-comparative-study-of-metabolic-tumor-volume-in-multiple-myeloma-and-related-plasma-cell-dyscrasias-11c-acetate-pet-vs-18f-fdg-pet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.71605","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,16]]}}}